Temperature control in sepsis.

antipyretics body temperature fever prognosis sepsis septic shock

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2023
Historique:
received: 19 09 2023
accepted: 17 10 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

Fever can be viewed as an adaptive response to infection. Temperature control in sepsis is aimed at preventing potential harms associated with high temperature (tachycardia, vasodilation, electrolyte and water loss) and therapeutic hypothermia may be aimed at slowing metabolic activities and protecting organs from inflammation. Although high fever (>39.5°C) control is usually performed in critically ill patients, available cohorts and randomized controlled trials do not support its use to improve sepsis prognosis. Finally, both spontaneous and therapeutic hypothermia are associated with poor outcomes in sepsis.

Identifiants

pubmed: 38020082
doi: 10.3389/fmed.2023.1292468
pmc: PMC10644266
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1292468

Informations de copyright

Copyright © 2023 Doman, Thy, Dessajan, Dlela, Do Rego, Cariou, Ejzenberg, Bouadma, de Montmollin and Timsit.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Ann Hematol. 2015 May;94(5):857-64
pubmed: 25516454
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22357-22366
pubmed: 32839313
Crit Care Med. 2022 Jun 1;50(6):924-934
pubmed: 35120040
Crit Care Med. 1999 Apr;27(4):699-707
pubmed: 10321658
PLoS One. 2017 Jan 12;12(1):e0170152
pubmed: 28081244
Arch Intern Med. 1998 Sep 28;158(17):1870-81
pubmed: 9759682
Lancet Respir Med. 2018 Mar;6(3):183-192
pubmed: 29325753
Crit Care. 2016 Jul 14;20(1):200
pubmed: 27411542
BMJ. 2022 Jul 12;378:e069620
pubmed: 35820685
Sci Rep. 2022 Apr 15;12(1):6244
pubmed: 35428797
Minerva Anestesiol. 2012 Nov;78(11):1254-64
pubmed: 22772856
Curr Opin Crit Care. 2022 Apr 1;28(2):130-137
pubmed: 35058405
Am J Respir Crit Care Med. 2023 May 15;207(10):1300-1309
pubmed: 36449534
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6388-93
pubmed: 17405864
Sci Transl Med. 2022 Nov 16;14(671):eabo3445
pubmed: 36383683
Comp Med. 2017 Dec 1;67(6):491-497
pubmed: 29212580
Intensive Care Med. 2019 Apr;45(4):468-476
pubmed: 30741326
Prog Brain Res. 2007;162:347-71
pubmed: 17645927
Crit Care. 2016 Oct 3;20(1):303
pubmed: 27716372
Pharmacol Res Perspect. 2022 Apr;10(2):e00925
pubmed: 35218614
Ther Hypothermia Temp Manag. 2020 Jun;10(2):102-105
pubmed: 31233381
Fundam Clin Pharmacol. 2008 Jun;22(3):285-9
pubmed: 18485146
Clin Infect Dis. 2012 Apr;54(8):1064-70
pubmed: 22291110
Crit Care. 2013 Dec 10;17(6):R289
pubmed: 24326145
Antimicrob Agents Chemother. 2010 Oct;54(10):4078-84
pubmed: 20679509
Am J Pathol. 2003 Jun;162(6):2005-17
pubmed: 12759256
Infect Immun. 1992 Aug;60(8):3448-51
pubmed: 1639514
J Immunol. 2005 Mar 15;174(6):3676-85
pubmed: 15749906
Crit Care. 2010;14(3):R125
pubmed: 20591173
J Clin Med. 2022 Feb 24;11(5):
pubmed: 35268302
Front Immunol. 2019 Oct 18;10:2374
pubmed: 31681277
Intensive Care Med. 2012 Jan 31;:
pubmed: 22290072
Crit Care. 2007;11(4):R91
pubmed: 17718920
N Engl J Med. 1997 Mar 27;336(13):912-8
pubmed: 9070471
Stroke. 2008 Nov;39(11):3029-35
pubmed: 18723420
Semin Thromb Hemost. 2018 Oct;44(7):651-655
pubmed: 29920620
Lancet Respir Med. 2018 Mar;6(3):162-163
pubmed: 29325752
J Immunol. 2010 Apr 1;184(7):3801-13
pubmed: 20200273
Open Forum Infect Dis. 2021 Mar 31;8(6):ofab161
pubmed: 34476283
Nature. 2014 Oct 30;514(7524):638-41
pubmed: 25274297
Crit Care Med. 2008 Apr;36(4):1330-49
pubmed: 18379262
Can Respir J. 2017;2017:3087505
pubmed: 28386165
Am J Respir Crit Care Med. 2019 Aug 1;200(3):327-335
pubmed: 30789749
J Gen Intern Med. 2006 Nov;21(11):1184-7
pubmed: 17026728
Handb Clin Neurol. 2018;157:789-797
pubmed: 30459041
Crit Care Med. 2012 Jan;40(1):145-51
pubmed: 21926588
Cell Death Dis. 2016 Oct 27;7(10):e2437
pubmed: 27787523
Crit Care Med. 1991 Nov;19(11):1339-47
pubmed: 1935150
Blood Adv. 2021 Oct 26;5(20):3937-3950
pubmed: 34478486
Crit Care. 2021 Oct 21;25(1):368
pubmed: 34674733
Gac Med Mex. 2021;157(4):377-383
pubmed: 35133331
J Pak Med Assoc. 2016 Oct;66(10):1303-1306
pubmed: 27686309
Crit Care Med. 2017 May;45(5):806-813
pubmed: 28221185
Crit Care Med. 2019 May;47(5):691-699
pubmed: 30789402
Int J Antimicrob Agents. 1999 Jan;11(1):81-5
pubmed: 10075283
Anaesthesia. 2021 May;76(5):655-664
pubmed: 33399225
Crit Care. 2013 Sep 12;17(5):R200
pubmed: 24028682
Cell Stress Chaperones. 2000 Nov;5(5):471-80
pubmed: 11189454
Am J Respir Crit Care Med. 2012 May 15;185(10):1088-95
pubmed: 22366046
Intensive Care Med. 2004 May;30(5):811-6
pubmed: 15127194
Shock. 2019 Aug;52(2):152-159
pubmed: 31058720
Antibiotics (Basel). 2021 Aug 21;10(8):
pubmed: 34439066
J Infect Dis. 1982 Apr;145(4):550-3
pubmed: 7069235
Circulation. 2015 Jul 21;132(3):152-7
pubmed: 26092672
Resuscitation. 2013 Aug;84(8):1056-61
pubmed: 23153649
Crit Care. 2012 Feb 28;16(1):R33
pubmed: 22373120
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1030-1041
pubmed: 36378114
N Engl J Med. 2019 Jun 20;380(25):2449-2459
pubmed: 31216400
N Engl J Med. 2015 Dec 3;373(23):2215-24
pubmed: 26436473
Am J Respir Crit Care Med. 2020 Mar 1;201(5):555-563
pubmed: 31973575
Intensive Care Med. 2022 Mar;48(3):261-269
pubmed: 35089409
Crit Care. 2020 Jun 30;24(1):387
pubmed: 32605659
J Inflamm Res. 2021 Jun 17;14:2619-2631
pubmed: 34168484
Infect Immun. 1986 May;52(2):484-7
pubmed: 3699893
Front Physiol. 2023 Jul 26;14:1215686
pubmed: 37565142
PLoS One. 2020 Jun 19;15(6):e0234656
pubmed: 32559761
Crit Care. 2004 Dec;8(6):R474-82
pubmed: 15566594

Auteurs

Marc Doman (M)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Michael Thy (M)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Inserm UMR 1137 - IAME Team 5 - Decision Sciences in Infectious Diseases, Control and Care INSERM/Paris Diderot, Sorbonne Paris Cité University, Paris, France.

Julien Dessajan (J)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Mariem Dlela (M)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Hermann Do Rego (H)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Erwann Cariou (E)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Michael Ejzenberg (M)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

Lila Bouadma (L)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Inserm UMR 1137 - IAME Team 5 - Decision Sciences in Infectious Diseases, Control and Care INSERM/Paris Diderot, Sorbonne Paris Cité University, Paris, France.

Etienne de Montmollin (E)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Inserm UMR 1137 - IAME Team 5 - Decision Sciences in Infectious Diseases, Control and Care INSERM/Paris Diderot, Sorbonne Paris Cité University, Paris, France.

Jean-François Timsit (JF)

Medical ICU, Paris Cité University- Bichat University Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.
Inserm UMR 1137 - IAME Team 5 - Decision Sciences in Infectious Diseases, Control and Care INSERM/Paris Diderot, Sorbonne Paris Cité University, Paris, France.

Classifications MeSH